Page 180 - HIV/AIDS Guidelines
P. 180

Table 13. Antiretroviral Therapy-Associated Common and/or Severe Adverse Effects

                              (See Appendix B for additional information listed by drug.)  (Page 4 of 4)




                                    Adverse Effects                                   NRTIs                                 NNRTIs                           PIs                             INSTI                EI


                                Lipodystrophy                 Lipoatrophy: Thymidine analogs (d4T > ZDV). May be       Lipohypertophy: Trunk fat increase observed with EFV-, PI-, and RAL-containing
                                                              more likely when combined with EFV than with a           regimens; however, causal relationship has not been established.
                                                              ritonavir-boosted PI.

                                Myopathy/elevated creatine    ZDV: myopathy                                                                                                        RAL: ↑ CPK. muscle
                                phosphokinase (CPK)                                                                                                                                weakness and
                                                                                                                                                                                   rhabdomyolysis

                                Nephrotoxicity/               TDF: ↑ serum creatinine, proteinuria,                                         IDV: ↑ serum creatinine, pyuria;
                                urolithiasis                  hypophosphatemia, urinary phosphate wasting,                                  hydronephrosis or renal atrophy
                                                              glycosuria, hypokalemia, non-anion gap metabolic
                                                                                                                                            IDV, ATV: Stone, crystal formation;
                                                              acidosis
                                                                                                                                            adequate hydration may reduce risk.
                                                              Concurrent use of PI may increase risk.


                                Osteopenia/                   TDF: Associated with greater loss of BMD than ZDV,       Decreases in BMD observed in studies of regimens
                                osteoporosis                  d4T, and ABC.                                            containing different NRTIs combined with either NNRTIs or
                                                                                                                       PIs.

                                Peripheral neuropathy         Peripheral neuropathy (pain and/or paresthesias, lower
                                                              extremities > upper extremities): d4T > ddI and ddC
                                                              (can be irreversible)

                                Rash                                                                                   All NNRTIs           ATV, DRV, FPV                          RAL: Uncommon               MVC



                                Stevens-Johnson syndrome      ddI, ZDV: Reported cases                                 NVP > DLV, EFV,      FPV, DRV, IDV, LPV/r, ATV: Reported    RAL
                                (SJS)/ toxic epidermal                                                                 ETR, RPV             cases
                                necrosis (TEN)

                              Key to Abbreviations: 3TC = lamivudine, ABC = abacavir, ALT = alanine aminotransferase, ARV = antiretroviral, AST = aspartate aminotransferase, ATV = atazanavir, ATV/r = atazanavir + ritonavir, BMD = bone mineral
                              density, CNS = central nervous system, CPK = creatine phosphokinase, CVD = cardiovascular disease, d4T = stavudine, ddC = zalcitabine, ddI = didanosine, DLV = delaviridine, DM = diabetes mellitus,
                              DRV = darunavir, DRV/r = darunavir + ritonavir, ECG = electrocardiogram, EFV = efavirenz, EI = entry inhibitor, ETR = etravirine, FPV = fosamprenavir, FPV/r = fosamprenavir + ritonavir, FTC = emtricitabine,
                              GI = gastrointestinal, HBV = hepatitis B virus, HDL = high-density lipoprotein, HSR = hypersensitivity reaction, IDV = indinavir, INSTI = integrase strand transfer inhibitor, LDL = low-density lipoprotein,
                              LPV/r = lopinavir + ritonavir, MI = myocardial infarction, MVC = maraviroc, NFV = nelfinavir, NNRTI = non-nucleoside reverse transcriptase inhibitor, NRTI = nucleoside reverse transcriptase inhibitor,
                              NVP = nevirapine, PI = protease inhibitor, PT = prothrombin time, RAL = raltegravir, RPV = rilpivirine, RTV = ritonavir, SJS = Stevens-Johnson syndrome, SQV = saquinavir, SQV/r = saquinavir + ritonavir,
                              TDF = tenofovir, TEN = toxic epidermal necrosis, TG = triglyceride, TPV = tipranavir, TPV/r = tipranavir + ritonavir, ZDV = zidovudine











                              Guidelines for the Use of Antiretroviral Agents in HIV-1-Infected Adults and Adolescents                                                                                                              K-11
                                                                               Downloaded from http://aidsinfo.nih.gov/guidelines on 12/8/2012 EST.
   175   176   177   178   179   180   181   182   183   184   185